Bidding on Medarex

Bristol-Myers Squibb Co. (NYSE:BMY) started bidding for Medarex Inc. (NYSE:MEDX) with a $9-$10 per share bid in April. The negotiations ultimately led to a final price of $16 at the end of July. Below...